comparemela.com

Latest Breaking News On - Selecta biosciences - Page 14 : comparemela.com

Gout Therapeutics Market to be Worth $4 13 Billion by 2030: Grand View Research, Inc

Selecta Biosciences, Inc (NASDAQ:SELB) Short Interest Update

Selecta Biosciences, Inc. (NASDAQ:SELB – Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 11,230,000 shares, an increase of 26.3% from the June 15th total of 8,890,000 shares. Currently, 10.3% of the shares of the company are […]

Selecta Biosciences, Inc (NASDAQ:SELB) Sees Significant Increase in Short Interest

Selecta Biosciences, Inc. (NASDAQ:SELB – Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totalling 11,230,000 shares, a growth of 26.3% from the June 15th total of 8,890,000 shares. Currently, 10.3% of the company’s stock are sold short. Based on an […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.